Chisato Izumi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chisato Izumi has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Makoto Miyake
Tenri Hospital
11 shared publications - Toshihiro Tamura
Department of Cardiology, Tenri Hospital, Japan (T.T.).
10 shared publications - Yoshihisa Nakagawa
Department of Cardiology, Tenri Hospital
10 shared publications Hirokazu Kondo
8 shared publications- Kazuaki Kaitani
Tenri Hospital
8 shared publications Yodo Tamaki
8 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S40
Incidence and Predictors of Thromboembolic Events after Anticoagulant Therapy in Patients with Left Ventricular Thrombus
- 1 October 2017
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (10) , S40
Incidence and Predictors of Thromboembolic Events after Anticoagulant Therapy in Patients with Left Ventricular Thrombus
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S192
5 m Walking Time is Well Correlated With Peak Oxygen Consumption (Peak VO2) in Chronic Heart Failure Patients
- 1 September 2016
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 22 (9) , S192
5 m Walking Time is Well Correlated With Peak Oxygen Consumption (Peak VO2) in Chronic Heart Failure Patients
- 13 April 2016
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 30 (6) , 941-946
The Influence of Assay Selection on Prothrombin Time Measured in Patients Treated With Rivaroxaban for Nonvalvular Atrial Fibrillation
Prothrombin time (PT) can provide a qualitative assessment of the relative intensity of anticoagulation by rivaroxaban. More than ten types of assay are available for the measurement of PT in clinical settings, but it is not yet fully understood whether their interactions with rivaroxaban are uniform or inconsistent. We examined 139 blood samples from patients taking rivaroxaban. We measured PT using five different commercially available assays. We also evaluated the estimated rivaroxaban concentration using a chromogenic anti-factor Xa assay. The median estimated concentration of rivaroxaban was 192 ng/ml (interquartile range 85-284 ng/ml). The correlation coefficient (r) between PT and the estimated concentrations of rivaroxaban was as follows: Thromborel S, r = 0.768; Thrombocheck PT, r = 0.861; Coagpia PT-N, r = 0.909; Neoplastin Plus, r = 0.882; and Triniclot PT Excel S, r = 0.870. The gradients of the regression plots differed more than fourfold, and the standard deviation of the regression line ranged from 1.001 to 2.980, which tended to be higher for the assays with the higher regression slope gradients. The estimated concentration of rivaroxaban varied greatly depending on the assay, so the PT measured in patients taking rivaroxaban should be interpreted with caution.
- 13 April 2016
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 30 (6) , 941-946
The Influence of Assay Selection on Prothrombin Time Measured in Patients Treated With Rivaroxaban for Nonvalvular Atrial Fibrillation
Prothrombin time (PT) can provide a qualitative assessment of the relative intensity of anticoagulation by rivaroxaban. More than ten types of assay are available for the measurement of PT in clinical settings, but it is not yet fully understood whether their interactions with rivaroxaban are uniform or inconsistent. We examined 139 blood samples from patients taking rivaroxaban. We measured PT using five different commercially available assays. We also evaluated the estimated rivaroxaban concentration using a chromogenic anti-factor Xa assay. The median estimated concentration of rivaroxaban was 192 ng/ml (interquartile range 85-284 ng/ml). The correlation coefficient (r) between PT and the estimated concentrations of rivaroxaban was as follows: Thromborel S, r = 0.768; Thrombocheck PT, r = 0.861; Coagpia PT-N, r = 0.909; Neoplastin Plus, r = 0.882; and Triniclot PT Excel S, r = 0.870. The gradients of the regression plots differed more than fourfold, and the standard deviation of the regression line ranged from 1.001 to 2.980, which tended to be higher for the assays with the higher regression slope gradients. The estimated concentration of rivaroxaban varied greatly depending on the assay, so the PT measured in patients taking rivaroxaban should be interpreted with caution.
- 1 January 2016
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 55 (12) , 1605-1609
Multiple Coronary Artery Aneurysms and Thoracic Aortitis Associated with IgG4-related Disease
A 60-year-old man was admitted due to the onset of right coronary artery (RCA) aneurysms. Coronary angiography showed two RCA aneurysms and focal stenosis with limitations in the blood flow. Balloon angioplasty was performed. However, the follow-up coronary angiography showed restenosis, an enlarged proximal aneurysm and a newly formed aneurysm. The serum immunoglobulin G4 level was elevated to 1,350 mg/dL and fluorodeoxyglucose positron emission tomography showed increased uptake in the ascending aorta, so the patient was diagnosed with immunoglobulin G4-related vascular disease. The prevention of further enlargement of the aneurysms and an improvement in the RCA flow were achieved with steroid therapy. Steroid therapy may therefore be effective for immunoglobulin G4-related vascular disease.
- 1 January 2016
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 55 (12) , 1605-1609
Multiple Coronary Artery Aneurysms and Thoracic Aortitis Associated with IgG4-related Disease
A 60-year-old man was admitted due to the onset of right coronary artery (RCA) aneurysms. Coronary angiography showed two RCA aneurysms and focal stenosis with limitations in the blood flow. Balloon angioplasty was performed. However, the follow-up coronary angiography showed restenosis, an enlarged proximal aneurysm and a newly formed aneurysm. The serum immunoglobulin G4 level was elevated to 1,350 mg/dL and fluorodeoxyglucose positron emission tomography showed increased uptake in the ascending aorta, so the patient was diagnosed with immunoglobulin G4-related vascular disease. The prevention of further enlargement of the aneurysms and an improvement in the RCA flow were achieved with steroid therapy. Steroid therapy may therefore be effective for immunoglobulin G4-related vascular disease.
- 1 November 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (9) , 1431-1435
Surgical Outcomes and Postoperative Prognosis Beyond 10 Years for Double-Chambered Right Ventricle
- 1 November 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (9) , 1431-1435
Surgical Outcomes and Postoperative Prognosis Beyond 10 Years for Double-Chambered Right Ventricle
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , OP36_1
Contraction of Left Atrial Appendage before and after Radiofrequency Catheter Ablation: Assessment with 320-Slice Computed Tomography
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , OP36_1
Contraction of Left Atrial Appendage before and after Radiofrequency Catheter Ablation: Assessment with 320-Slice Computed Tomography
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (10) , 2152-2157
Impact of Aortic Plaque Morphology on Survival Rate and Incidence of a Subsequent Embolic Event
There are no reports about the long-term follow-up data of patients with aortic plaques among the Japanese population. The purpose of this study was to clarify the frequency of patients with severe aortic plaques and the impact of aortic plaque morphology on the prognosis. We retrospectively investigated 1,570 consecutive patients who underwent transesophageal echocardiography. Survival rate and subsequent embolic event rate were compared between patients with severe aortic plaque (>5 mm in thickness) and control patients. The relationship between aortic plaque morphology and prognosis was also estimated according to the presence of ulceration, calcification, hypoechoic plaques, and mobile plaques. The mean follow-up period was 8.7 years. Among 1,570 patients, severe aortic plaque was detected in 92 patients (5.9%). These 92 patients showed a significantly low survival rate and high subsequent embolic event rate compared to control patients (5-year survival rate: 69% vs 94%; 5-year embolic event free rate: 52% vs 95%). Among patients with severe aortic plaque, only ulceration was associated with a low survival rate (hazards ratio: 2.4, 95% confidence interval (CI): 1.1-5.2) and only mobile plaque was associated with a high embolic event rate (hazards ratio: 2.2; 95%CI: 1.1-5.1). Aortic plaque >5 mm in thickness was a predictor of poor prognosis. In the presence of aortic plaque >5 mm, ulceration was a predictor of a low survival rate and mobile plaque was a predictor of a high embolic event rate.
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (10) , 2152-2157
Impact of Aortic Plaque Morphology on Survival Rate and Incidence of a Subsequent Embolic Event
There are no reports about the long-term follow-up data of patients with aortic plaques among the Japanese population. The purpose of this study was to clarify the frequency of patients with severe aortic plaques and the impact of aortic plaque morphology on the prognosis. We retrospectively investigated 1,570 consecutive patients who underwent transesophageal echocardiography. Survival rate and subsequent embolic event rate were compared between patients with severe aortic plaque (>5 mm in thickness) and control patients. The relationship between aortic plaque morphology and prognosis was also estimated according to the presence of ulceration, calcification, hypoechoic plaques, and mobile plaques. The mean follow-up period was 8.7 years. Among 1,570 patients, severe aortic plaque was detected in 92 patients (5.9%). These 92 patients showed a significantly low survival rate and high subsequent embolic event rate compared to control patients (5-year survival rate: 69% vs 94%; 5-year embolic event free rate: 52% vs 95%). Among patients with severe aortic plaque, only ulceration was associated with a low survival rate (hazards ratio: 2.4, 95% confidence interval (CI): 1.1-5.2) and only mobile plaque was associated with a high embolic event rate (hazards ratio: 2.2; 95%CI: 1.1-5.1). Aortic plaque >5 mm in thickness was a predictor of poor prognosis. In the presence of aortic plaque >5 mm, ulceration was a predictor of a low survival rate and mobile plaque was a predictor of a high embolic event rate.